Charity News

Fight for Sight and Retina UK funded researchers identify new cause of inherited eye condition – retinitis pigmentosa

Researchers funded in partnership by Fight for Sight and Retina UK have identified a new cause of the most common inherited eye condition, which will allow for work to begin on the development of potential treatments for the condition, in results published in the American Journal of Human Genetics on October 5th 2020.

Retinitis pigmentosa is the term used for a group of closely related inherited eye conditions that affect the retina, the specialised light-sensitive tissue at the back of the eye. The condition, which causes degenerative sight loss and can eventually lead to blindness, affects around one in 4,000 people in the UK.

The research was led by Professor Alison Hardcastle at UCL Institute of Ophthalmology and her collaborator in The Netherlands, Dr Susanne Roosing. The team identified the new cause of dominant retinitis pigmentosa in 22 families, affecting over 300 individuals, which until now had remained unsolved for over 35 years. Most changes identified as the cause of retinal diseases affect the sequence of a gene, however in these families, researchers identified complex re-arrangements of the chromosome as the cause of the condition.

Professor Hardcastle’s team then used patient stem cells to investigate how complex re-arrangements of this part of the chromosome might lead to retinal degeneration. They found that the chromosome structure was altered so that a gene (GDPD1) which should be ignored by the retinal cells was instead ‘read’, leading to the malfunction.

Professor Hardcastle said:

“This discovery represents a new mechanism of retinal disease, and new understanding of how alterations of the human genome can cause inherited conditions. We hope our discovery and new knowledge will now lead to many more similar discoveries. It was such a pleasure to work with our international collaborators, including researchers in Cape Town and Berlin. Now that we understand the genetic basis for the disease, we can start developing potential treatments to slow disease progression and preserve vision.”

Director of Research at Fight for Sight, Dr Neha Issar-Brown said:

Professor Hardcastle’s findings are incredibly important for the 22 families directly involved in this study, but they also demonstrate the potential for identifying other causes of inherited conditions - for eye research and beyond. This will undoubtedly help in the search for new treatments and cures for these eye conditions, which have lacked mechanistic understanding and therefore, treatment pathways. Professor Hardcastle’s work represents an important breakthrough and shows that more research is vital to find the causes, treatment and cures for sight loss now and in the future.”

A graphic depicting the research. Previously implicated disease causing variant was CA4. No pathogenic variant. iPSC with an arrow directed to photoreceptor precursor cells, controls and SV1. Another arrow to retinal organoids, controls and SV2. Hi-C analysis. Two graphs show a healthy retina and RP17 retina. The RP17 retina has higher peaks. Another graphic depicting qPCR analysis. The healthy retina and the RP17 retina are identical except the former has low expression of GDPD1 and the latter has high.

Related content

Paul Sladen pictured with his grandma on an outing together
Charity News
Running for Macular Degeneration
Running for Macular Degeneration
Two women cheering on runners at a challenge event
Charity News
Volunteer to cheer on our London Marathon runners
Volunteer to cheer on our London Marathon runners
Keith Valentine and Steven White standing next to each other.
Charity News
Q&A: Talking Cure Usher with its Vice Chair and Co-founder
Q&A: Talking Cure Usher with its Vice Chair and Co-founder